text: Recent studies have reported that << imatinib mesylate >>, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the [[ platelet derived growth factor (PDGF) receptor ]], is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.